KCM
DMAC icon

Kalehua Capital Management’s DiaMedica Therapeutics DMAC Stock Holding History

Kalehua Capital Management’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-62,488
Closed -$423K – 27
2026
Q1 		$423K Sell
62,488
-32,871
-34% -$260K 0.3% 24
2025
Q4 		$759K Buy
+95,359
New +$713K 0.75% 19

Other funds holding DMAC

CLG
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Kalehua Capital Management's DMAC Position: Q2 2026 in Review

Kalehua Capital Management sold out of DiaMedica Therapeutics (DMAC) in Q2 2026, closing a stake of 62,488 shares — an estimated $423K sold.

Kalehua Capital Management first reported a position in DMAC in Q4 2025 and held it in 2 quarters. The position peaked at $759K in Q4 2025. 89 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

  • Kalehua Capital Management reported no remaining DiaMedica Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Kalehua Capital Management sold 62,488 DiaMedica Therapeutics shares in Q2 2026, an estimated $423K.
  • Kalehua Capital Management first reported a position in DiaMedica Therapeutics in Q4 2025 and held it in 2 quarters.
  • Kalehua Capital Management's DiaMedica Therapeutics position peaked at $759K in Q4 2025.
  • 89 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on Kalehua Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.